Determination of ligand-protein dissociation constants by electrospray mass spectrometry-based diffusion measurements.
A novel approach for the quantification of ligand-protein interactions is presented. Electrospray ionization mass spectrometry (ESI-MS) is used to monitor the diffusion behavior of noncovalent ligands in the presence of their protein receptors. These data allow the fraction of free ligand in solution to be determined, such that the corresponding dissociation constants can be calculated. A set of conditions is developed that provides an "allowable range" of concentrations for this type of assay. The method is tested by applying it to two different inhibitor-enzyme systems. The dissociation constants measured for benzamidine-trypsin and for N,N',N' '-triacetylchitotriose-lysozyme are (50 +/- 10) and (6 +/- 1) mM, respectively. Both of these results are in good agreement with previous data from the literature. In contrast to traditional ESI-MS-based methods, the approach used in this work does not rely on the preservation of specific solution-type noncovalent interactions in the gas phase. It is shown that this method allows an accurate determination of dissociation constants, even in cases in which the ion abundance ratio of free to ligand-bound protein in ESI-MS does not reflect the corresponding concentration ratio in solution.
Clark
Sonya M
SM
Department of Chemistry, The University of Western Ontario, London, Ontario N6A 5B7, Canada.
Konermann
Lars
L
D001550:Benzamidines / Q000032:analysis* / Q000494:pharmacology; D004058:Diffusion; D004791:Enzyme Inhibitors / Q000032:analysis* / Q000494:pharmacology; D008024:Ligands; D009113:Muramidase / Q000032:analysis* / Q000037:antagonists & inhibitors; D011485:Protein Binding / Q000187:drug effects; D012680:Sensitivity and Specificity; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D013329:Structure-Activity Relationship; D013997:Time Factors; D014312:Trisaccharides / Q000032:analysis* / Q000494:pharmacology; D014357:Trypsin / Q000032:analysis* / Q000187:drug effects
D001550:Benzamidines; D004791:Enzyme Inhibitors; D008024:Ligands; D014312:Trisaccharides; C019117:N,N',N''-triacetylchitotriose; D009113:Muramidase; D014357:Trypsin; C032157:benzamidine